GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Buildings And Improvements

JW Pharmaceutical (XKRX:001060) Buildings And Improvements : ₩79,640 Mil (As of Dec. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Buildings And Improvements?

JW Pharmaceutical's quarterly buildings and improvements declined from Jun. 2024 (₩51,446 Mil) to Sep. 2024 (₩50,905 Mil) but then increased from Sep. 2024 (₩50,905 Mil) to Dec. 2024 (₩79,640 Mil).

JW Pharmaceutical's annual buildings and improvements increased from Dec. 2022 (₩77,758 Mil) to Dec. 2023 (₩79,361 Mil) and increased from Dec. 2023 (₩79,361 Mil) to Dec. 2024 (₩79,640 Mil).

JW Pharmaceutical Buildings And Improvements Historical Data

The historical data trend for JW Pharmaceutical's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Buildings And Improvements Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99,980.10 77,658.82 77,757.95 79,361.36 79,640.16

JW Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79,361.36 51,938.53 51,446.41 50,904.89 79,640.16

JW Pharmaceutical Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

JW Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Buildings And Improvements
Comparable Companies
XKRX:206650 XKRX:084110 XKRX:041960 XKRX:220100 XKRX:170900 XKRX:047920 XKRX:200670 XKRX:000640 XKRX:019170 XKRX:003520 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
001067:Korea 001065.PFD:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines